Pacer Advisors’s Q32 Bio QTTB Stock Holding History

Pacer Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-87	Closed	-$17K	–	1543
2020 Q3	$17K	Buy	+87	New	+$19.5K	﹤0.01%	1359

Other funds holding QTTB

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pacer Advisors's QTTB Position: Q4 2020 in Review

Pacer Advisors sold out of Q32 Bio (QTTB) in Q4 2020, closing a stake of 87 shares — an estimated $17K sold.

Pacer Advisors first reported a position in QTTB in Q3 2020 and held it in 1 quarter. The position peaked at $17K in Q3 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q4 2020.

Pacer Advisors reported no remaining Q32 Bio position as of Q4 2020 after selling out during the quarter.
Pacer Advisors sold 87 Q32 Bio shares in Q4 2020, an estimated $17K.
Pacer Advisors first reported a position in Q32 Bio in Q3 2020 and held it in 1 quarter.
Pacer Advisors's Q32 Bio position peaked at $17K in Q3 2020.
106 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2020.

Based on Pacer Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.